4//SEC Filing
Kite Pharma, Inc. 4
Accession 0001209191-17-041303
CIK 0001510580operating
Filed
Jun 21, 8:00 PM ET
Accepted
Jun 22, 2:35 PM ET
Size
6.8 KB
Accession
0001209191-17-041303
Insider Transaction Report
Form 4
Ruchefsky Steven B
Director
Transactions
- Award
Director Stock Option (Right to Buy)
2017-06-20+8,810→ 8,810 totalExercise: $91.21Exp: 2027-06-19→ Common Stock (8,810 underlying) - Award
Common Stock
2017-06-20+2,410→ 207,836 total
Footnotes (1)
- [F1]The stock option shall vest in 12 successive equal monthly installments following the date of grant.
Documents
Issuer
Kite Pharma, Inc.
CIK 0001510580
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001510580
Filing Metadata
- Form type
- 4
- Filed
- Jun 21, 8:00 PM ET
- Accepted
- Jun 22, 2:35 PM ET
- Size
- 6.8 KB